Evidence map›Paper›PMID 36949485›Full record

ArticleTrials2023

Strengthening primary care for diabetes and hypertension in Eswatini: study protocol for a nationwide cluster-randomized controlled trial.

Michaela Theilmann, Ntombifuthi Ginindza, John Myeni, Sijabulile Dlamini, Bongekile Thobekile Cindzi, Dumezweni Dlamini, Thobile L Dlamini, Maike Greve, Harsh Vivek Harkare, Mbuso Hleta and 20 more

Registry-linked trialOpen access · goldFull text readClinical Trial Protocol
In one paragraph

Article in Trials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04183413 (Strengthening Primary Healthcare Delivery for Diabetes and Hypertension in Eswatini), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
7.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04183413 nacompletednot on this map

Strengthening Primary Healthcare Delivery for Diabetes and Hypertension in Eswatini: A Cluster-randomized Trial

TypeinterventionalSponsorUniversity Hospital HeidelbergRan2021 to 2023Enrolled3,500ConditionsDiabetes Mellitus, HypertensionArmsDSD, CDP
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 12 institutions in 7 countries.

Michaela TheilmannHeidelberg Institute of Global Health, Heidelberg University, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany. michaela.theilmann@uni-heidelberg.de.ORCID http://orcid.org/0000-0003-3413-232X
Ntombifuthi GinindzaMinistry of Health in Eswatini, Ministry of Justice & Constitutional Affairs Building, Mhlambanyatsi Road, Mbabane, Eswatini.
John MyeniMinistry of Health in Eswatini, Ministry of Justice & Constitutional Affairs Building, Mhlambanyatsi Road, Mbabane, Eswatini.
Sijabulile DlaminiMinistry of Health in Eswatini, Ministry of Justice & Constitutional Affairs Building, Mhlambanyatsi Road, Mbabane, Eswatini.
Bongekile Thobekile CindziClinton Health Access Initiative, Mbhilibhi House, Plot 170, Corner Tsekwane/Mbhilibhi Street, Mbabane, Eswatini.
Dumezweni DlaminiDiabetes Eswatini, Manzini, Eswatini.
Thobile L DlaminiEswatini Business Health and Wellness, Malagwane Hill, Mbabane, Eswatini.
Maike GreveUniversity of Göttingen, Humboldtallee 3, 37073, Göttingen, Germany.
Harsh Vivek HarkareSwiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123, Allschwil, Switzerland.
Mbuso HletaEswatini Business Health and Wellness, Malagwane Hill, Mbabane, Eswatini.
Philile KhumaloDiabetes Eswatini, Manzini, Eswatini.
Lutz M KolbeUniversity of Göttingen, Humboldtallee 3, 37073, Göttingen, Germany.
Simon LewinDivision of Health Services, Norwegian Institute of Public Health, Oslo, Norway.ORCID http://orcid.org/0000-0001-7521-9515
Lisa-Rufaro MarowaClinton Health Access Initiative, Mbhilibhi House, Plot 170, Corner Tsekwane/Mbhilibhi Street, Mbabane, Eswatini.
Sakhile MasukuUniversity of Eswatini, M48V+JXG, Mbabane, Eswatini.
Dumsile MavusoDiabetes Eswatini, Manzini, Eswatini.
Marjan MolemansAmsterdam Institute for Global Health and Development, Paasheuvelweg 25, 1105 BP, Amsterdam, Netherlands.
Nyasatu NtshalintshaliClinton Health Access Initiative, Mbhilibhi House, Plot 170, Corner Tsekwane/Mbhilibhi Street, Mbabane, Eswatini.
Nomathemba NxumaloUniversity of Eswatini, M48V+JXG, Mbabane, Eswatini.
Brianna OsetinskySwiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123, Allschwil, Switzerland.
Christopher PellAmsterdam Institute for Global Health and Development, Paasheuvelweg 25, 1105 BP, Amsterdam, Netherlands.
Ria ReisAmsterdam Institute for Global Health and Development, Paasheuvelweg 25, 1105 BP, Amsterdam, Netherlands.
Fortunate ShabalalaUniversity of Eswatini, M48V+JXG, Mbabane, Eswatini.
Bongumusa R SimelaneEswatini Business Health and Wellness, Malagwane Hill, Mbabane, Eswatini.
Lisa StehrHeidelberg Institute of Global Health, Heidelberg University, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.
Fabrizio TediosiSwiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123, Allschwil, Switzerland.
Frank van LethAmsterdam Public Health Research Institute, Amsterdam, Netherlands.
Jan-Walter De NeveHeidelberg Institute of Global Health, Heidelberg University, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.
Till Bärnighausen *Heidelberg Institute of Global Health, Heidelberg University, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.
Pascal Geldsetzer *Division of Primary Care and Population Health, Stanford University, 291 Campus Drive, Stanford, CA, 94305-5101, USA. pgeldsetzer@gmail.com.
Heidelberg University · DEClinton Health Access Initiative · USMinistry of Health · SZSouthern Africa Nazarene University · SZSwiss Tropical and Public Health Institute · CHUniversity of Eswatini · SZAmsterdam Institute for Global Health and Development · NLUniversity of Göttingen · DESouth African Medical Research Council · ZAStanford Health Care · USUniversity of Cape Town · ZAVrije Universiteit Amsterdam · NL

Funding

Horizon 2020 825823
6 · The paper itself

Abstract

backgroundDiabetes and hypertension are increasingly important population health challenges in Eswatini. Prior to this project, healthcare for these conditions was primarily provided through physician-led teams at tertiary care facilities and accessed by only a small fraction of people living with diabetes or hypertension. This trial tests and evaluates two community-based healthcare service models implemented at the national level, which involve health care personnel at primary care facilities and utilize the country's public sector community health worker cadre (the rural health motivators [RHMs]) to help generate demand for care.

methodsThis study is a cluster-randomized controlled trial with two treatment arms and one control arm. The unit of randomization is a primary healthcare facility along with all RHMs (and their corresponding service areas) assigned to the facility. A total of 84 primary healthcare facilities were randomized in a 1:1:1 ratio to the three study arms. The first treatment arm implements differentiated service delivery (DSD) models at the clinic and community levels with the objective of improving treatment uptake and adherence among clients with diabetes or hypertension. In the second treatment arm, community distribution points (CDPs), which previously targeted clients living with human immunodeficiency virus, extend their services to clients with diabetes or hypertension by allowing them to pick up medications and obtain routine nurse-led follow-up visits in their community rather than at the healthcare facility. In both treatment arms, RHMs visit households regularly, screen clients at risk, provide personalized counseling, and refer clients to either primary care clinics or the nearest CDP. In the control arm, primary care clinics provide diabetes and hypertension care services but without the involvement of RHMs and the implementation of DSD models or CDPs. The primary endpoints are mean glycated hemoglobin (HbA1c) and systolic blood pressure among adults aged 40 years and older living with diabetes or hypertension, respectively. These endpoints will be assessed through a household survey in the RHM service areas. In addition to the health impact evaluation, we will conduct studies on cost-effectiveness, syndemics, and the intervention's implementation processes. DISCUSSION: This study has the ambition to assist the Eswatini government in selecting the most effective delivery model for diabetes and hypertension care. The evidence generated with this national-level cluster-randomized controlled trial may also prove useful to policy makers in the wider Sub-Saharan African region.

trial registrationNCT04183413. Trial registration date: December 3, 2019.

Indexed as

Diabetes MellitusHypertensionAdultDelivery of Health CareEswatiniHumansMiddle AgedPrimary Health CareRandomized Controlled Trials as TopicCardiovascular diseaseCommunity health workerCommunity outreachDiabetesDifferentiated service deliveryEswatiniHealth service decentralizationHypertensionNon-communicable diseaseWHO-PEN

Identifiers

PMID36949485
PMCPMC10031170
OpenAlexW4360599982

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read41
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.